Skip to content

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07196917
Enrollment
1000000
Registered
2025-09-29
Start date
2025-10-01
Completion date
2027-12-31
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cardiovascular Diseases, Death, Endocrine System Diseases, Respiratory Tract Diseases

Brief summary

To further explore the application prospects of integrated Traditional Chinese and Western medicine in chronic disease prevention and control and health management, this study intends to establish a large, prospective, integrated Traditional Chinese and Western medicine cohort in Hubei Province. This study will conduct long-term follow-up and multi-dimensional data collection to systematically reveal the associations between Traditional Chinese Medicine (TCM) constitution types and chronic diseases, the aging process, and multi-morbidity, thereby developing an integrated health management strategy with local characteristics. This study will fill the current gap in systematic evidence linking TCM constitutions to the prevalence of modern diseases, providing a solid demographic and biological foundation for the integrated development of Traditional Chinese and Western medicine. It will also contribute to meeting the needs for early disease warning, early intervention, and personalized care under the Healthy China strategic goal.

Interventions

None listed

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CollaboratorOTHER
Hubei College of Traditional Chinese Medicine
CollaboratorOTHER
Hubei Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Hubei Provincial Center for Disease Control and Prevention
CollaboratorOTHER
Wuhan Center for Disease Control and Prevention
CollaboratorUNKNOWN
Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

Age: Participants aged 30 to 74 years Physical Functionality: Free from severe physical disabilities impacting mobility or communication, with preserved ability to comprehend and respond to study procedures Informed Consent: Capable of providing written informed consent voluntarily after receiving full study disclosure

Exclusion criteria

Residents living in functional areas (e.g., work sheds, military units, student dormitories, nursing homes, etc.) Individuals unable to communicate normally

Design outcomes

Primary

MeasureTime frame
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in ChinaFrom enrollment to the 10-year follow-up
Incidence of major chronic diseases (coronary heart disease, stroke, diabetes, COPD, lung cancer, colorectal cancer, gastric cancer, liver cancer, and esophageal cancer)From baseline (enrollment) to 10-year follow-up Measurement Tool: Standardized physician-adjudicated diagnosis based on ICD-10 codes, confirmed through hospital electronic medical records and disease registries

Secondary

MeasureTime frameDescription
All-cause mortalityFrom baseline to 10-year follow-upTime Frame: From baseline to 10-year follow-up Measurement Tool: Death registry linkage and hospital records Unit of Measure: Mortality rate per 1,000 person-years

Other

MeasureTime frameDescription
Cause-specific mortality (cardiovascular, cancer, respiratory, metabolic)From baseline to 10-year follow-upTime Frame: From baseline to 10-year follow-up Measurement Tool: Death registry and ICD-10 coded cause of death Unit of Measure: Mortality rate per 1,000 person-years
Prevalence and progression of multimorbidity (≥2 chronic conditions)Baseline to 10-year follow-upTime Frame: Baseline to 10-year follow-up Measurement Tool: Questionnaire survey and physician-adjudicated diagnosis using ICD-10 Unit of Measure: % of participants with multimorbidity

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026